Posts

Posted on

Hewlett Packard Enterprise Drives Innovation at the Extreme Edge on the International Space Station with 24 Completed Experiments

Hewlett Packard Enterprise Drives Innovation at the Extreme Edge on the International Space Station with 24 Completed Experiments

Since launching to the ISS a year ago, HPE Spaceborne Computer-2 has accelerated time-to-insight, from months to minutes, to advance healthcare, image processing, natural disaster recovery, 3D printing, 5G, AI and more

HOUSTON–(BUSINESS WIRE)–Hewlett Packard Enterprise (NYSE: HPE) today announced that the HPE Spaceborne Computer-2 (SBC-2), the first in-space commercial edge computing and AI-enabled system to run on the International Space Station (ISS), has successfully completed 24 research experiments, accelerating time-to-insight from months and days, to minutes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220404005739/en/

HPE Spaceborne Computer-2 is the first commercial edge computing and AI solution installed on the International Space Station (May 2021). Image credit: NASA

HPE Spaceborne Computer-2 is the first commercial edge computing and AI solution installed on the International Space Station (May 2021). Image credit: NASA

The experiments involved real-time data processing and testing of new applications to prove reliability in space as part of an effort to increase autonomy for astronauts. These experiments spanned uses cases supporting healthcare, image processing, natural disaster recovery, 3D printing, 5G, and solutions enabled by artificial intelligence.

VIDEO:Northrop Grumman CRS-15: HPE Spaceborne Computer-2 accelerates space exploration with first ever in-space commercial edge computing and artificial intelligence capabilities

“By introducing edge computing and AI capabilities to the International Space Station with Spaceborne Computer-2, we have helped foster a growing, collaborative research community that shares a common goal to make scientific and engineering breakthroughs that benefit humankind, on space and here on Earth,” said Dr. Mark Fernandez, principal investigator, Spaceborne Computer-2, at HPE. “We are proud of this ongoing work, which has already resulted in 24 completed experiments, from various organizations, demonstrating new possibilities for space exploration and milestones for humanity.”

Breaking ground for edge computing and AI in space with Spaceborne Computer-2

HPE launched Spaceborne Computer-2, in collaboration with the ISS National Laboratory, to space in February 2021 and was installed on the ISS in May 2021. The solution is comprised of HPE’s edge computing solutions, the HPE Edgeline Converged EL4000 Edge system, which provides a rugged and compact system designed to perform in harsher edge environments, such as space, and the HPE ProLiant DL360 server, a trusted, industry-standard server, for additional high-performing capabilities to target a range of workloads, including edge, HPC, AI, etc.

SBC-2 is part of a greater mission to significantly advance computing and reduce dependence on communications as humans travel farther into space to the Moon, Mars and beyond. The solution also demonstrates potential ways astronauts can increase self-sufficiency when processing data directly on the space station, in real-time, bypassing longer latency and wait times that occur when relying on sending raw data to Earth to be processed, analyzed, and sent back to space.

Enabling faster computing and shorter download times to Earth with 20,000X speed-up

The edge computing capabilities delivered through SBC-2 also have the potential to enable astronauts and space explorers to send data to Earth, whether to be further analyzed or used in another way, at a radically compressed size and faster speed. Previously, 1.8 GB of raw DNA sequence data took an average time of 12.2 hours just to download to Earth for initial processing. With SBC-2, researchers onboard the space station processed that same data in six minutes to gather meaningful insights, compressed it to 92 KB and sent it to Earth in just two seconds, representing a 20,000X speed-up.1

Spaceborne Computer-2 completes 24 experiments using in-space edge computing and AI

Since its installment on the ISS, Spaceborne Computer-2 ran dozens of experiments by processing data at the edge, in real-time, for researchers with organizations developing breakthrough capabilities for space exploration such as Axiom Space, Cornell University, Comucore, Microsoft, NASA and Titan Space Technologies. Example experiments include:

  • Experiment focused on increasing human safety and self-sufficiency by using AI-enabled damage detection in astronaut gloves– Astronauts on the ISS are often on spacewalks where they repair equipment, install new instruments and upgrade features and functions on the space station. They wear essential gloves that can experience natural erosion, along with even rips and cuts, that can present potential safety concerns. In an experiment led by NASA, HPE and Microsoft, photos and recorded video taken in space of recently worn gloves by astronauts, were processed using Spaceborne Computer-2’s AI-enabled capabilities. The glove analyzer model, jointly developed by NASA and Microsoft, was then used to rapidly look for signs of damage on-orbit, in space. If damage is detected, an AI-annotated photo is generated in space and immediately sent to Earth, highlighting areas for further review by NASA engineers.
  • Automatic interpretation of satellite imagery after a disaster – NASA Jet Propulsion Laboratory observes Earth from space to study science and climate, as well as support disaster response. Using Spaceborne Computer-2 in concert with embedded processors, NASA JPL tested several deep learning inference networks to automatically interpret remote sensed images from land and structures after a disaster. For example, two such techniques use radar data from the UAVSAR platform to: determine flood extent, such as from a hurricane, and to determine urban building damage, such as from an earthquake. These techniques could be used onboard future spacecraft to rapidly deliver actionable products to relevant authorities to assist in disaster recovery.
  • Enabling 3D printing in space with validated software– As humans look to future deep space travel, ordering supplies to repair or build new equipment from Earth will not be timely and practical. To increase self-sufficiency by enabling additive manufacturing for humans traveling beyond low Earth orbit (LEO), Cornell Fracture Group, part of Cornell University, a leading research university, developed a modeling software that can simulate 3D printing of metal parts and even predict any failure and deformation that may result when printing in the harsh condition of space. The software was successfully tested on Spaceborne Computer-2, validating that it can be used in space to digitally simulate a part and understand how it will perform in reality.
  • Expanding network capability on the ISS with a 5G core prototype – Cumucore, a private mobile network solution provider, tested its 5G core network, along with RAN emulators and other features, on Spaceborne Computer-2, to emulate current capabilities on the base station and end user devices. The validation demonstrated the potential to install state-of-the-art 5G capabilities on selected satellites and spacecraft to unlock a new level of communications in space. The validation also has the potential to support near future opportunities using 5G due to the rapid expansion of the commercialization of space.
  • Developing software codes to calculate fuel requirements based on space travel distance – As part of HPE’s ongoing work with students worldwide to mentor and support efforts in STEM research, HPE opened up Spaceborne Computer-2 to students in India involved in Codewars, an educational community and competition for computer programming. The projects largely focused on developing code using C++, Python and Fortran, with one involving C++ Pythagoras theorem code to calculate how much fuel is needed for given space travel distance to directly travel to without requiring refueling.

Join HPE at Space Symposium – April 4-7, 2022

HPE is exhibiting at the annual 37th Space Symposium conference in Colorado Springs, Colorado, at booth #1457

HPE, NASA and Microsoft will demo the AI Hand Glove experiment at the HPE booth during the conference.

Dr. Mark Fernandez, principal investigator of Spaceborne Computer-2 at HPE, will also present in the following panel:

To learn more about Spaceborne Computer-2 and how to submit a proposal to use the system, please visit: www.hpe.com/info/spaceborne

About Hewlett Packard Enterprise

Hewlett Packard Enterprise (NYSE: HPE) is the global edge-to-cloud company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the future and innovating to advance the way people live and work, HPE delivers unique, open and intelligent technology solutions as a service. With offerings spanning Cloud Services, Compute, High Performance Computing & AI, Intelligent Edge, Software, and Storage, HPE provides a consistent experience across all clouds and edges, helping customers develop new business models, engage in new ways, and increase operational performance. For more information, visit: www.hpe.com

1 Based on data logged on HPE Spaceborne Computer-2 on a DNA sequencing experiment

Nahren Khizeran

[email protected]

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Data Management Technology Aerospace Manufacturing Software Hardware

MEDIA:

Photo
Photo
HPE Spaceborne Computer-2 is the first commercial edge computing and AI solution installed on the International Space Station (May 2021). Image credit: NASA
Posted on

PGA Champion Jason Day Launches Getting Out of the Rough Video Series With AstraZeneca to Support Lung Cancer Biomarker Testing Awareness

PR Newswire

Campaign aims to increase understanding of the role of biomarker testing to complete a lung cancer diagnosis


WASHINGTON
, April 4, 2022 /PRNewswire/ — Jason Day, pro-golfer and PGA Champion, joins AstraZeneca to launch the Getting Out of the Rough campaign, aimed to educate lung cancer patients and their caregivers about biomarker testing and the importance of completing a lung cancer diagnosis through this approach. The Getting Out of the Rough campaign features a six-episode video series, where Jason is joined by friends from the worlds of medicine and entertainment to discuss and learn about adapting after you or someone you love has been diagnosed with lung cancer. Among the group is Modern Family star Julie Bowen, whose series episode premiered today, as well as actors Anthony Anderson and Bellamy Young, happiness expert Shawn Achor, oncologist Dr. Mark Socinski and Jason’s wife, Ellie Day.

Jason Day, pro-golfer and PGA Champion, joins AstraZeneca to launch the Getting Out of the Rough campaign. 

Jason’s mother, Dening, was diagnosed with Stage IV non-small cell lung cancer (NSCLC), in 2017. Jason immediately stepped into the roles of caregiver and advocate to ensure that she received the best care possible—which for Dening included access to comprehensive biomarker testing. Biomarker testing can help reveal information about your specific type of lung cancer. This will help you and your healthcare team determine your treatment plan. Although Dening passed away in March 2022, she was able to spend extended time with her family— the extra time that Jason’s wife Ellie refers to as a “silver lining.”

“I’m honored to be launching the Getting Out of the Rough campaign. The issue of lung cancer and biomarker testing is deeply personal to me. When my mother was diagnosed with Stage IV lung cancer, we felt hopeless and did not know what kinds of treatment options existed at the time, nor what would work best for her,” said Jason Day. “It wasn’t until her healthcare team suggested comprehensive biomarker testing that suddenly new treatment options quickly became possible. Before my mom’s diagnosis, I had never heard of biomarker testing or targeted therapy.”

To help share information about Getting Out of the Rough, Jason is joined by medical oncologist and lung cancer specialist, Dr. Mark Socinski, who specializes in non-small cell and small-cell lung cancer. In their episode, Dr. Socinski speaks with Jason on the importance of having a well-thought-out treatment plan and how to work with your healthcare team to discuss all your options when faced with a lung cancer diagnosis.

“Just like golf is about aiming for a specific target, comprehensive biomarker testing can help you and your doctor get a complete diagnosis and determine the best path forward for treatment of lung cancer,” said Dr. Socinski. “Today, we have several drugs that target these biomarkers, but you can’t use the drugs appropriately unless you find the target. That’s why I encourage all my patients to consider comprehensive biomarker testing.”

To learn more about Getting Out of the Rough and watch episode 1, please visit www.diagnosisstories.com.

About Getting Out of the Rough

Getting Out of the Rough encourages lung cancer patients and caregivers to obtain a complete diagnosis through comprehensive biomarker testing. For more information on Getting Out of the Rough, visit www.diagnosisstories.com.

About AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pga-champion-jason-day-launches-getting-out-of-the-rough-video-series-with-astrazeneca-to-support-lung-cancer-biomarker-testing-awareness-301517014.html

SOURCE AstraZeneca

Posted on

New Research Affirms Increase in Access, Equity of COVID-19 Vaccines Administered in Dialysis Centers

PR Newswire

Results demonstrate the importance of vaccinating patients at trusted sites of care


DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ — A federal partnership established to help increase access to COVID-19 vaccines for end stage kidney disease (ESKD) patients receiving dialysis was successful in reducing racial disparities in vaccination coverage, new research published today in JAMA Internal Medicine affirms. Compared to white patients, Hispanic, Black and Asian patients were more likely to receive at least one dose of COVID-19 vaccine in a dialysis center.

The Centers for Disease Control and Prevention (CDC) collaborated with DaVita, Fresenius Medical Care North America and other partners in March 2021 to create the Federal Dialysis Provider COVID-19 Vaccine Partnership. Both providers received allocations of COVID-19 vaccines from the federal government to administer to patients in dialysis centers and distribute to other dialysis providers across the country.

“We were steadfast in our advocacy efforts to support patients with kidney failure by providing access to the vaccine through the pandemic. We’re incredibly grateful for the collaboration between the CDC and the kidney care community to leverage our capacity, experience and footprint to bring dialysis patients direct access to COVID-19 vaccines,” said Dr. Jeff Giullian, chief medical officer for DaVita and study co-author. “The results of this study affirm that providing vaccines at trusted sites of care is an effective approach to helping to reduce hesitancy and advance equity for patients of color who have been disproportionately affected by the COVID-19 pandemic.”

“I appreciate all the members of our frontline care teams who worked so hard to efficiently vaccinate our vulnerable patient population,” said Dr. Jeffrey Hymes, global head of clinical affairs for Fresenius Medical Care and another study co-author. “This important partnership with the CDC shows how well our dialysis centers can be used to reach often underserved populations and improve equitable access to care, especially for people at highest risk of complications from viruses like COVID-19.”

The new study evaluated the impact of dialysis clinics serving as COVID-19 vaccine providers on vaccination coverage and disparities from Dec. 1, 2020, through June 13, 2021. Vaccination coverage was calculated using the number of patients at nearly 5,200 Fresenius and DaVita dialysis centers who received at least one dose of vaccine, regardless of location. Researchers found that:

  • As of March 28, 2021, shortly after the federal partnership launched, vaccination coverage among white patients was 52%, exceeding coverage in Black (45.2%) and Hispanic (51.3%) patients. Asian patients had higher vaccination coverage (60%) than white patients.
  • By June 13, 2021, vaccination coverage among Asian (74.1%) and Hispanic (69.5%) patients exceeded that of white patients (65.5%), with vaccination coverage among Black patients slightly lower (63%).
  • Overall, 50.7% (312,046) of vaccinated patients were vaccinated in a dialysis clinic during the evaluation. Compared to white patients (42.5%), Hispanic (62.2%), Black (55.4%) and Asian (49.5%) patients were more likely to receive the COVID-19 vaccine in a dialysis center.

The researchers recommend that public health agencies and policymakers prioritize dialysis centers for federal vaccine allocations and on-site vaccine administration in the future.

More than 500,000 Americans diagnosed with ESKD receive life-sustaining dialysis care. Due to underlying conditions that may compromise their immune systems, these patients are often at higher risk for COVID-19 infection. ESKD patients are also some of the most racially and ethnically diverse in health care.

Study author affiliations: Fresenius Medical Care, DaVita Inc., Minnesota Department of Health, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention detailed to Puerto Rico Department of Health, American Society of Nephrology and Yale University School of Medicine, and the American Society of Nephrology and Rogosin Institute.

About DaVita Inc.

DaVita (NYSE: DVA) is a comprehensive kidney care provider focused on transforming care to improve the quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita is working to help increase equitable access to care for patients at every stage and setting along their kidney health journey—from slowing progression of kidney disease to streamlining the transplant process, from acute hospital care to dialysis at home. As of December 31, 2021, DaVita served 203,000 patients at 2,815 outpatient dialysis centers in the U.S. The company operated an additional 339 outpatient dialysis centers in ten countries worldwide. DaVita has reduced hospitalizations, improved mortality and worked collaboratively to propel the kidney care community to adopt an equitable, high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

About Fresenius Medical Care North America

Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.

Media Contact Information:

DaVita
Halie Peddle
(303) 550-6349
[email protected] 

Fresenius Medical Care North America
Brad Puffer
(781) 699-3331
[email protected]

Cision View original content:https://www.prnewswire.com/news-releases/new-research-affirms-increase-in-access-equity-of-covid-19-vaccines-administered-in-dialysis-centers-301517013.html

SOURCE DaVita

Posted on

PolarisRZR Factory Racing Wins Big at the 2022 San Felipe 250

PolarisRZR Factory Racing Wins Big at the 2022 San Felipe 250

Wayne Matlock Wins the 35th SCORE San Felipe 250 Behind the Wheel of the All-New RZR Pro R

Matlock, Mike Cafro & Craig Scanlon sweep Pro Open Class Podium, Justin Lambert Wins Pro Turbo Class & Places Second Overall

MINNEAPOLIS–(BUSINESS WIRE)–
The Polaris RZR Factory Racing team put together an impressive performance at the 35th running of the King Shocks SCORE San Felipe 250, with Wayne Matlock taking the overall win in the new RZR Pro R and Polaris sweeping the top three Pro UTV classes. The Polaris Factory Team commanded the field as Matlock dominated the Pro Open class in route to the overall victory, while Justin Lambert took second overall and first in the Pro Turbo Class. Finishing the day was Joe Bolton, winning the Pro Naturally Aspirated Class aboard his RZR XP1000.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220404005833/en/

Polaris RZR Factory Racing driver Wayne Matlock takes the overall win in the new RZR Pro R. (Photo: Business Wire)

Polaris RZR Factory Racing driver Wayne Matlock takes the overall win in the new RZR Pro R. (Photo: Business Wire)

“Today was an awesome day for the whole Polaris Racing team. We came into this weekend ready to make a statement, and that is exactly what we did,” said Brett Carpenter, Manager of the Polaris Factory Racing Team. “Wayne drove flawlessly all day to capture the win. This showing is a testament to the capabilities of our racers, but also the RZR Pro R platform. These vehicles are incredibly durable and capable of handling even the toughest conditions, which was showcased today.”

Throughout the 277-mile race, Matlock methodically navigated his Pro R across the rugged Baja desert to take the checkered flag and win in 6 hours, 8 minutes, and 50 seconds, nearly 5 minutes faster than the next vehicle. Wayne started the race in pole position in his class; however, he’d need to work through the dust of nearly 30 other UTVs in the Pro Turbo class ahead of him to contend for the overall UTV crown. He’d do just that. By mile 45, Wayne had already worked his way through half of the pack.

Polaris Racing teammate Justin Lambert set a blistering pace and held the first physical position all day while feeling the pressure of 30 other Pro class UTV’s behind him. Just over halfway through the race, Polaris Factory Racing drivers were in the lead in all three Pro classes.

At mile 215, Justin Lambert was still out front as the physical leader and in contention for the overall on corrected time. Meanwhile, the unforgiving Baja terrain would put Wayne Matlock’s Pro R to the test, where he’d face some downtime in Matomi Wash, one of the most notoriously rough sections of Baja. After regrouping, Matlock put his foot down to have a chance at the overall win. He put together an impressive charge, passing half a dozen vehicles in the last 50 miles to secure the top spot in the Pro UTV Open class and capture the overall win, beating Polaris teammate Justin Lambert who secured the Pro UTV Turbo class win.

Mike Cafro and Craig Scanlon rounded out the podium in Pro UTV Open, giving the Polaris Factory Racing team a podium sweep in that class. In the Pro Naturally Aspirated class, Joe Bolton came away with the win after battling hard and swapping the lead position multiple times with Polaris racer Kaden Wells and the Risq Racing team.

While celebrating his victory, Wayne Matlock said, “This RZR was on absolute rails all day. This is by far one of the roughest off-road desert races we compete at and the Pro R handled it flawlessly.” Matlock continued by explaining, “Baja threw everything it had at us but this Matlock Racing team never gave up and we just kept pushing to the front. I can’t wait to get back down to Baja in this Pro R for the 500!”

Polaris RZR Factory Racing will be back in action at the Baja 500 on June 1-5, 2022.

More information about Polaris Off-Road Vehicles and Polaris Engineered Accessories can be found at RZR.Polaris.com. Also, join the conversation and follow RZR on Facebook, Instagram and Twitter.

About Polaris

As the global leader in Powersports, Polaris Inc. (NYSE: PII) pioneers product breakthroughs and enriching experiences and services that have invited people to discover the joy of being outdoors since our founding in 1954. With annual 2021 sales of $8.2 billion, Polaris’ high-quality product line-up includes the Polaris RANGER®, RZR® and Polaris GENERAL™ side-by-side off-road vehicles; Sportsman® all-terrain off-road vehicles; Indian Motorcycle® mid-size and heavyweight motorcycles; Slingshot® moto-roadsters; snowmobiles; and deck, cruiser and pontoon boats, including industry-leading Bennington pontoons. Polaris enhances the riding experience with parts, garments, and accessories, along with a growing aftermarket portfolio, including Transamerican Auto Parts. Polaris’ presence in adjacent markets includes military and commercial off-road vehicles, quadricycles, and electric vehicles. Proudly headquartered in Minnesota, Polaris serves more than 100 countries across the globe. www.polaris.com

Mandie Albert

[email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Off-Road Trucks & SUVs General Automotive Motorcycles General Sports Extreme Sports Automotive Manufacturing Manufacturing Aftermarket Automotive Sports Outdoors Motor Sports Other Automotive Performance & Special Interest

MEDIA:

Photo
Photo
Polaris RZR Factory Racing driver Wayne Matlock takes the overall win in the new RZR Pro R. (Photo: Business Wire)
Posted on

KRATON EXPANDS AMS RESIN CAPACITY AT NIORT FACILITY TO SUPPORT CUSTOMER GROWTH

PR Newswire


HOUSTON
, April 4, 2022 /PRNewswire/ — Kraton Corporation, a leading global sustainable producer of specialty polymers and high-value biobased products derived from pine wood pulping co-products, announces a significant investment in its Alpha Methyl Styrene (AMS) Resins facility in Niort, France. Kraton expects the investment will result in a 15% production increase at the Niort manufacturing facility by 2023. In addition to the capacity increase, Kraton anticipates the investment will lead to a 70% reduction in solvent consumption, creating a favorable impact on the product life cycle by the end of 2022. 

Kraton’s AMS Resins, also known as Pure Monomer Resins, are sold in high-end applications such as Tread Enhancement Additives for premium tires and as high-performance tackifying resins in fast-growing adhesive markets. Kraton’s SYLVATRAXX™ Tread Enhancement Additives improve the overall performance of tire treads in terms of wet grip, low rolling resistance, and durability, thus enabling safer driving, better fuel efficiency and range. Due to increasingly stringent car emission standards across the globe, these high-performance additives have seen substantial demand growth.

“The rise in Electric Vehicles (EV) also contributes to this growth, as the increased EV weight and higher torque bring new challenges in tire performance,” said Torsten Schmidt, Vice President of Commercial, Kraton Pine Chemicals. “Our SYLVATRAXX products continue to gain popularity across the entire tire value chain as they enable our customers to meet these new requirements.”

In recent years, Kraton has made significant investments in AMS Resins at the manufacturing facility in Niort, resulting in added operational capacity and improved asset reliability. As customer demand increases, the new growth project focuses on advancing production efficiencies while improving the site’s environmental footprint.

In parallel with the current expansion projects, Kraton is exploring additional manufacturing expansion opportunities at the Niort plant beyond the 2023 horizon.

About Kraton Corporation  
Kraton Corporation is a leading global sustainable producer of specialty polymers and high-value biobased products derived from pine wood pulping co-products. Kraton’s polymers are used in a wide range of applications, including adhesives, coatings, consumer and personal care products, sealants and lubricants, medical, packaging, automotive, paving and roofing applications. As the largest global provider in the pine chemicals industry, the company’s pine-based specialty products are sold into adhesive, road and construction and tire markets, and it produces and sells a broad range of performance chemicals into markets that include fuel additives, oilfield chemicals, coatings, metalworking fluids and lubricants, inks and mining. Kraton offers its products to a diverse customer base in numerous countries worldwide. Kraton and the Kraton logo are registered trademarks of Kraton Corporation, or its subsidiaries or affiliates, in one or more, but not all countries.  

Media Contact: 
Kristen Boyd:
(281) 504-4986

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kraton-expands-ams-resin-capacity-at-niort-facility-to-support-customer-growth-301517005.html

SOURCE Kraton Corporation

Posted on

ACCO Brands Corporation Announces First Quarter 2022 Earnings Webcast

ACCO Brands Corporation Announces First Quarter 2022 Earnings Webcast

LAKE ZURICH, Ill.–(BUSINESS WIRE)–
ACCO Brands Corporation (NYSE: ACCO) today announced that it will release its first quarter 2022 earnings after the market close on April 26, 2022. The Company will host a conference call and webcast to discuss the results on April 27 at 8:30 a.m. EDT. The webcast can be accessed through the Investor Relations section of www.accobrands.com and will be available for replay.

About ACCO Brands Corporation

ACCO Brands Corporation (NYSE: ACCO) is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include Artline®, AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni®, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones® and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Christine Hanneman

Investor Relations

(847) 796-4320

Julie McEwan

Media Relations

(937) 974-8162

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Retail Home Goods Office Products Other Retail

MEDIA:

Logo
Logo
Posted on

The Central and Eastern Europe Fund, Inc. Provides Updated Portfolio Holdings Information

The Central and Eastern Europe Fund, Inc. Provides Updated Portfolio Holdings Information

NEW YORK–(BUSINESS WIRE)–
The Central and Eastern Europe Fund, Inc. (NYSE: CEE) (the “Fund”) announced today that it has provided updated portfolio holdings information as of March 31, 2022 at www.dwsfunds.com (immediately following this press release in the “Press releases” portion of the Fund’s main web page). The updated holdings information reflects changes made to the Fund’s portfolio since March 14, 2022. As of March 31, 2022, the Fund continues to hold securities of certain Russian issuers that are subject to United States and other sanctions. The Fund continues to believe that it is in compliance with all applicable sanctions requirements.

For more information on the Fund, visit www.dwsfunds.com or call (800) 349-4281.

IMPORTANT INFORMATION

Investing in foreign securities, particularly those of emerging markets, presents certain risks, such as currency fluctuations and risks of currency and capital controls, political and economic changes, and market risks. Any fund that concentrates in a particular segment of the market will generally be more volatile than a fund that invests more broadly.

The Central and Eastern Europe Fund, Inc. is non-diversified and can take larger positions in fewer issues, increasing its potential risk, and also concentrates its investments in the energy sector. Investing in foreign securities presents certain risks, such as currency fluctuations, currency and capital controls, political and economic changes, and market risks. Emerging markets tend to be more volatile and less liquid than the markets of more mature economies and generally have less diverse and less mature economic structures and less stable political systems than those of developed countries. Any fund that focuses in a particular segment of the market or region of the world will generally be more volatile than a fund that invests more broadly.

The shares of most closed-end funds, including the Fund, are not continuously offered. Once issued, shares of closed-end funds are bought and sold in the open market through a stock exchange. Shares of closed-end funds frequently trade at a discount to net asset value. The price of a fund’s shares is determined by a number of factors, several of which are beyond the control of the fund. Therefore, a fund cannot predict whether its shares will trade at, below, or above net asset value.

Investments in funds involve risk. Additional risks of the Fund are associated with international investing, such as currency fluctuations, currency and capital controls, political and economic changes, market risks, government regulations and differences in liquidity, which may increase the volatility of your investment. Foreign security markets generally exhibit greater price volatility and are less liquid than the US market. Additionally, the Fund focuses its investments in certain geographical regions, thereby increasing its vulnerability to developments in that region and potentially subjecting the Fund’s shares to greater price volatility. Some funds have more risk than others. These include funds, such as the Fund, that allow exposure to or otherwise concentrate investments in certain sectors, geographic regions, security types, market capitalization, or foreign securities (e.g., political, or economic instability, which can be accentuated in emerging market countries).

War (including Russia’s recent invasion of Ukraine), US and other sanctions, terrorism, economic uncertainty, trade disputes, trading halts, currency and capital controls, public health crises (including the recent pandemic spread of the novel coronavirus) and related geopolitical events could lead to increased market volatility, disruption to US and world economies and markets and may have significant adverse effects on the Fund and its investments, including making investments illiquid and/or difficult to value.

This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.

Certain statements contained in this release may be forward-looking in nature. These include all statements relating to plans, expectations, and other statements that are not historical facts and typically use words like “expect,” “anticipate,” “believe,” “intend,” and similar expressions. Such statements represent management’s current beliefs, based upon information available at the time the statements are made, with regard to the matters addressed. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Management does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. The following factors, among others, could cause actual results to differ materially from forward-looking statements: (i) the effects of adverse changes in market and economic conditions; (ii) legal and regulatory developments; and (iii) other additional risks and uncertainties, including public health crises (including the recent pandemic spread of the novel coronavirus), war, terrorism, trade disputes and related geopolitical events.

Past performance is no guarantee of future results.

NOT FDIC/ NCUA INSURED • MAY LOSE VALUE • NO BANK GUARANTEE

NOT A DEPOSIT • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY

DWS Distributors, Inc.

222 South Riverside Plaza

Chicago, IL 60606-5808

www.dws.com

Tel (800) 621-1148

© 2022 DWS Group GmbH & Co. KGaA. All rights reserved

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services. (R-089109) (04-2022)

For additional information:

DWS Press Office (212) 454-4500

Shareholder Account Information (800) 294-4366

DWS Closed-End Funds (800) 349-4281

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo
Posted on

American Water Recognized for Its Leadership and Commitment to Employees & Communities

American Water Recognized for Its Leadership and Commitment to Employees & Communities

Honored by Newsweek and VETS Indexes

CAMDEN, N.J.–(BUSINESS WIRE)–American Water (NYSE: AWK), the largest publicly traded U.S. water and wastewater utility company, announced today that it has been recognized on Newsweek’s 2022 list of America’s Most Trusted Companies and honored as a VETS Indexes 3 Star Employer. These recognitions illustrate American Water’s continued commitment to environmental, social and governance (ESG) principles.

American Water is the top-ranked water utility company on the Newsweek list and ranked 14th in the Energy and Utilities industry. Companies were selected based on a holistic approach to evaluating customer trust, investor trust and employee trust.

The VETS Indexes 3 Star Employer Award recognizes American Water’s commitment to recruit, hire, retain, develop and support veteran employees. The VETS Indexes Employer Awards are reserved for organizations who demonstrate an outstanding commitment to veterans and the military community.

Learn more about American Water’s commitment to ESG principles here.

About American Water

With a history dating back to 1886, American Water (NYSE: AWK) is the largest and most geographically diverse U.S. publicly traded water and wastewater utility company. The company employs more than 6,400 dedicated professionals who provide regulated and regulated-like drinking water and wastewater services to more than 14 million people in 24 states. American Water provides safe, clean, affordable and reliable water services to our customers to help keep their lives flowing. For more information, visit amwater.com and follow American Water on Twitter, Facebook, and LinkedIn.

Media:

Joseph Szafran

External Affairs Manager

(856) 955-4304

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Environment Human Resources Utilities Professional Services Philanthropy Energy Other Natural Resources Other Philanthropy Natural Resources

MEDIA:

Logo
Logo
Posted on

Artesian Resources Corporation 2021 Annual Report Available Electronically to Shareholders

NEWARK, Del., April 04, 2022 (GLOBE NEWSWIRE) — Artesian Resources Corporation (NASDAQ: ARTNA), a leading provider of water and wastewater services, and a number of other related core business services, on the Delmarva Peninsula, today announced that its 2021 Annual Report is available electronically to shareholders through its website at https://www.artesianwater.com/investor-relations/annual-report/. If any shareholder would like to receive a print copy of the 2021 Annual Report, they can request one free of charge by writing or calling Artesian Resources Corporation, 664 Churchmans Road, Newark, Delaware 19702, Attention Laura Slayman (Phone Number: 302-453-6900).

About Artesian Resources

Artesian Resources Corporation operates as a holding company of wholly-owned subsidiaries offering water and wastewater services, and a number of other related core business services, on the Delmarva Peninsula. Artesian Water Company, the principal subsidiary, is the oldest and largest regulated water utility on the Delmarva Peninsula and has been providing water service since 1905. Artesian supplies 8.4 billion gallons of water per year through 1,398 miles of main to over a third of Delawareans.

Contact:
Nicholle Taylor
Investor Relations
(302) 453-6900
[email protected]



Posted on

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

Maranello (Italy), April 4, 2022 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the sixth tranche of the common share buyback program announced on March 3, 2022 (“Sixth Tranche”), additional common shares – reported in aggregate form, on a daily basis – on Euronext Milan (EXM) as follows:

 

Trading

Date

(dd/mm/yyyy)

 

  

Stock Exchange

 

 

Number of common shares purchased

 

  

Average price per share


excluding fees


(€)

 

  

Consideration excluding fees

 

(€)

 

28/03/2022 EXM 4,213 194.7084 820,306.50
29/03/2022 EXM 6,358 197.5759 1,256,187.40
30/03/2022 EXM 7,300 199.5787 1,456,924.55
31/03/2022 EXM 6,586 200.2408 1,318,785.75
01/04/2022 EXM 8,246 199.2627 1,643,120.05
 

Total

 

 

–

 32,703 198.6155 6,495,324.25

(*) translated at the European Central Bank EUR/USD exchange reference rate as of the date of each purchase

Since the announcement of the Sixth Tranche of the buyback program dated March 3, 2022 till April 1, 2022, the total invested consideration has been:

  • Euro 32,314,842.55 for No. 175,175 common shares purchased on the EXM
  • USD 9,990,538.84 (Euro 9,133,362.89*) for No. 52,571 common shares purchased on the NYSE.

As of April 1, 2022, the Company held in treasury No. 10,655,951 common shares equal to 4.14% of the total issued share capital including the common shares and the special voting shares, net of shares assigned under the Company’s equity incentive plan.

Since January 1, 2019 until April 1, 2022, the Company has purchased a total of 5,536,233 own common shares on EXM and NYSE, excluding transactions for Sell to Cover, for a total consideration of Euro 844,868,771.99.

A comprehensive overview of the transactions carried out under the buyback program, as well as the details of the above transactions, are available on Ferrari’s corporate website under the Buyback Programs section (https://www.ferrari.com/en-EN/corporate/buyback-programs).

Attachment